Mentice AB (MNTC) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Mentice AB (MNTC) has a cash flow conversion efficiency ratio of 0.067x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr8.33 Million ≈ $896.66K USD) by net assets (Skr123.58 Million ≈ $13.30 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Mentice AB worth for the company's overall valuation and market capitalisation.
Mentice AB - Cash Flow Conversion Efficiency Trend (2017–2025)
This chart illustrates how Mentice AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Mentice AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Mentice AB ranked by their cash flow conversion efficiency. Explore Mentice AB earnings quality ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Manomay Tex India Limited
NSE:MANOMAY
|
-0.100x |
|
Grande Portage Resources Ltd
V:GPG
|
-0.019x |
|
Kaonmedia Co Ltd
KQ:078890
|
0.033x |
|
Asian Pac Holdings Bhd
KLSE:4057
|
-0.011x |
|
Eslite Spectrum
TWO:2926
|
0.889x |
|
NDL Ventures Limited
NSE:NDLVENTURE
|
0.000x |
|
Singular Health Group Ltd
AU:SHG
|
-0.266x |
|
Claranova SE
PA:CLA
|
-1.143x |
Annual Cash Flow Conversion Efficiency for Mentice AB (2017–2025)
The table below shows the annual cash flow conversion efficiency of Mentice AB from 2017 to 2025. View Mentice AB (MNTC) share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr138.38 Million ≈ $14.89 Million |
Skr-20.30 Million ≈ $-2.18 Million |
-0.147x | -217.61% |
| 2024-12-31 | Skr143.66 Million ≈ $15.46 Million |
Skr17.92 Million ≈ $1.93 Million |
0.125x | -45.70% |
| 2023-12-31 | Skr158.97 Million ≈ $17.11 Million |
Skr36.52 Million ≈ $3.93 Million |
0.230x | +150.59% |
| 2022-12-31 | Skr162.63 Million ≈ $17.50 Million |
Skr14.91 Million ≈ $1.60 Million |
0.092x | +344.60% |
| 2021-12-31 | Skr136.89 Million ≈ $14.73 Million |
Skr-5.13 Million ≈ $-552.07K |
-0.037x | -120.04% |
| 2020-12-31 | Skr163.25 Million ≈ $17.57 Million |
Skr30.53 Million ≈ $3.29 Million |
0.187x | +162.59% |
| 2019-12-31 | Skr124.77 Million ≈ $13.43 Million |
Skr-37.28 Million ≈ $-4.01 Million |
-0.299x | -224.60% |
| 2018-12-31 | Skr66.74 Million ≈ $7.18 Million |
Skr16.00 Million ≈ $1.72 Million |
0.240x | -25.85% |
| 2017-12-31 | Skr48.64 Million ≈ $5.23 Million |
Skr15.73 Million ≈ $1.69 Million |
0.323x | -- |
About Mentice AB
Mentice AB (publ), together with its subsidiaries, develops, sells, and markets solutions for training and decision support in the clinical area of interventional angiography in cardiology, neurology, vascular surgery, and radiology. It operates through the Mentice VIST, Physical Sim, and Ankyras segments. The company offers virtual simulation products, including VR simulator platforms; procedura… Read more